Organization
Lung Cancer Research Foundation (LCRF) and AstraZeneca
Type
Foundation
Link
LOI or Pre-Application Due Date
07-15-2026
Application Due Date
10-05-2026
Comments
LOI submission deadline is July 15, 2026. The full proposal submission deadline is October 5, 2026.
Brief Description
The 2026 LCRF | AstraZeneca Research Award on Strategies Using Patient Advocacy to Improve Outcomes in Small Cell Lung Cancer is a $250,000, two-year award that will focus on furthering the development of strategies towards improving the outcomes of SCLC patients through patient advocacy. Work supported through this mechanism will address important areas of need across the entire care continuum and have the immediate potential to increase research efforts, quality of life and survivorship.